<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>There is an increased prevalence of <z:hpo ids='HP_0000787'>nephrolithiasis</z:hpo> and an increase in the incidence of renal colic in patients with <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> because of an increased frequency of <z:chebi fb="3" ids="27226">uric acid</z:chebi> crystallization </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="3" ids="27226">Uric acid</z:chebi> crystallization occurs in the milieu of an acid urine and is not due to <z:hpo ids='HP_0003149'>hyperuricosuria</z:hpo> as with <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, urinary <z:chebi fb="3" ids="27226">uric acid</z:chebi> levels are generally decreased because of increased renal tubular reabsorption </plain></SENT>
<SENT sid="2" pm="."><plain>However, in the presence of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, there is decreased renal tubular generation of ammonia and increased <z:chebi fb="199" ids="26708">sodium</z:chebi> absorption leading to acidification of the urine and <z:chebi fb="3" ids="27226">uric acid</z:chebi> crystallization </plain></SENT>
<SENT sid="3" pm="."><plain>The presence of a low urine pH should alert the clinician to the increased risk of <z:hpo ids='HP_0000787'>nephrolithiasis</z:hpo> particularly in the <z:mp ids='MP_0001261'>obese</z:mp>, diabetic or hypertensive patient </plain></SENT>
<SENT sid="4" pm="."><plain>Prevention of <z:hpo ids='HP_0000787'>nephrolithiasis</z:hpo> can be achieved in susceptible individuals either by alkalizing the urine and/or by further decreasing the <z:chebi fb="3" ids="27226">uric acid</z:chebi> content of the urine with a <z:chebi fb="0" ids="35634">xanthine oxidase inhibitor</z:chebi> such as <z:chebi fb="0" ids="40279">allopurinol</z:chebi> </plain></SENT>
</text></document>